IPG Photonics (IPGP) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
8 Jul, 2026Executive summary
Q3 2024 revenue declined 23% year-over-year to $233 million, reaching the high end of guidance despite muted demand in industrial and e-mobility markets.
Net loss was $233.6 million (GAAP EPS: -$5.33), driven by a $198 million loss on Russian divestiture and $27 million in asset impairments; adjusted EPS was $0.29.
Completed sale of Russian operations and began winding down Belarusian operations due to sanctions, shifting manufacturing to other regions.
Announced acquisition of CleanLaser for ~$75 million to expand presence in the industrial cleaning market.
Continued investment in R&D, organizational improvements, and efficiency gains to drive long-term growth.
Financial highlights
Q3 2024 revenue was $233.1 million, down from $301.4 million in Q3 2023 and $257.6 million in Q2 2024.
GAAP gross margin was 23.2%, down from 44.1% a year ago, mainly due to inventory provisions and unabsorbed manufacturing costs; adjusted gross margin was 36%.
GAAP operating loss was $253 million, including $198 million loss on Russian asset sale and $27 million impairment from E.U. trade controls.
Adjusted net income was $12.9 million and adjusted EPS was $0.29, at the top end of guidance.
Cash from operations was $66 million; $23 million spent on capex and $74 million on share repurchases in Q3.
Outlook and guidance
Q4 2024 revenue expected between $210 million and $240 million, with gross margin of 35–38% and operating expenses of $78–80 million.
Q4 EPS guidance is $0.05–$0.35 per diluted share, excluding Russian operations; tax rate expected at 25%.
CleanLaser acquisition expected to add ~$30 million revenue in its first year, neutral to GAAP operating income.
Management expects continued investment in capacity outside Russia and Belarus, with $100 million in capital expenditures planned for 2024.
No visibility into improved demand; cautious outlook for near-term recovery.
Latest events from IPG Photonics
- Q2 2026 revenue up 11% with strong industrial demand, margin gains, and Lumibird Medical deal.IPGP
Q2 20264 Aug 2026 - €300M acquisition expands medical laser leadership, adds $1B market, and targets Q4 2026 close.IPGP
M&A announcement17 Jul 2026 - Q1 revenue beat guidance despite a 10% drop, with strong bookings and tariff-related Q2 risks.IPGP
Q1 20258 Jul 2026 - Revenue up 17% year-over-year, led by Industrial Solutions, but net income declined on higher costs.IPGP
Q1 20265 May 2026 - Growth, compensation realignment, and board-backed proposals mark a transformative year.IPGP
Proxy filing5 May 2026 - 2025 saw revenue growth, strong governance, performance-based pay, and expanded ESG oversight.IPGP
Proxy filing1 Apr 2026 - Votes will be cast on directors, executive pay, and auditor ratification at the May 2026 meeting.IPGP
Proxy filing1 Apr 2026 - Growth driven by innovation, new markets, and strong financials positions the business for expansion.IPGP
47th Annual Raymond James Institutional Investor Conference2 Mar 2026 - Q4 revenue up 17% year-over-year, with strong gains in medical and advanced applications.IPGP
Q4 202512 Feb 2026